USE OF RIBOSE IN FIRST RESPONSE TO ACUTE MYOCARDIAL INFARCTION

• 收藏
• 分享

专利权人:

发明人:

John A. St. Cyr,David J. Perkowski

申请号：

US15497421

公开号：

US20170326165A1

申请日:

2017.04.26

申请国别(地区):

US

年份:

2017

代理人:

摘要：

D-ribose is administered to patients suffering an acute myocardial infarction during first response care, in order to prevent cardiac compromise. In those patients able to ingest fluids, two to five grams of D-ribose is administered orally. In a patients unable to ingest fluids, or in a patient with and intravenous line, pyrogen-free D-ribose is administered intravenously at a rate of 50-300 mg/kg/hour.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/